Global Artificial Blood Market Research Report 2022
![](/report_cover/11318/global-artificial-blood-market-research-report-2022_en.gif)
Global Artificial Blood Market Overview:
Global Artificial Blood Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Artificial Blood involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artificial Blood Market
The Artificial Blood Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Artificial Blood Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artificial Blood Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Artificial Blood Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Artificial Blood market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Artificial Blood Market Segmentation
Global Artificial Blood Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Artificial Blood market has been segmented into:
Hemoglobin-Based Oxygen Carriers
Perflurocarbon-Based Products
Recombinant Factors
Synthetic Platelets
Plasma Expanders
Others
By Application, Artificial Blood market has been segmented into:
Traumatic Injuries
Blood Disorders
Anemia
Surgeries
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artificial Blood market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artificial Blood market.
Top Key Players Covered in Artificial Blood market are:
FluorO2 Therapeutics
Baxter International
Northfield Laboratories
Plasticell Limited
BioPure Corporation
Dentritech
Alpha Therapeutic Corp
Sangart
Dextro-Sang Corporation
Objective to buy this Report:
1. Artificial Blood analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Artificial Blood market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Artificial Blood Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Artificial Blood involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Artificial Blood Market
The Artificial Blood Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Artificial Blood Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Artificial Blood Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Artificial Blood Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Artificial Blood market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Artificial Blood Market Segmentation
Global Artificial Blood Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Artificial Blood market has been segmented into:
Hemoglobin-Based Oxygen Carriers
Perflurocarbon-Based Products
Recombinant Factors
Synthetic Platelets
Plasma Expanders
Others
By Application, Artificial Blood market has been segmented into:
Traumatic Injuries
Blood Disorders
Anemia
Surgeries
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Artificial Blood market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Artificial Blood market.
Top Key Players Covered in Artificial Blood market are:
FluorO2 Therapeutics
Baxter International
Northfield Laboratories
Plasticell Limited
BioPure Corporation
Dentritech
Alpha Therapeutic Corp
Sangart
Dextro-Sang Corporation
Objective to buy this Report:
1. Artificial Blood analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Artificial Blood market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 RESEARCH OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.3 RESEARCH PROCESS
1.4 SCOPE AND COVERAGE
1.4.1 MARKET DEFINITION
1.4.2 KEY QUESTIONS ANSWERED
1.5 MARKET SEGMENTATION
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 BY TYPE
3.2 BY APPLICATION
CHAPTER 4: MARKET LANDSCAPE
4.1 PORTER'S FIVE FORCES ANALYSIS
4.1.1 BARGAINING POWER OF SUPPLIER
4.1.2 THREAT OF NEW ENTRANTS
4.1.3 THREAT OF SUBSTITUTES
4.1.4 COMPETITIVE RIVALRY
4.1.5 BARGAINING POWER AMONG BUYERS
4.2 INDUSTRY VALUE CHAIN ANALYSIS
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 OPPORTUNITIES
4.5.4 CHALLENGES
4.4 PESTLE ANALYSIS
4.5 TECHNOLOGICAL ROADMAP
4.6 REGULATORY LANDSCAPE
4.7 SWOT ANALYSIS
4.8 PRICE TREND ANALYSIS
4.9 PATENT ANALYSIS
4.10 ANALYSIS OF THE IMPACT OF COVID-19
4.10.1 IMPACT ON THE OVERALL MARKET
4.10.2 IMPACT ON THE SUPPLY CHAIN
4.10.3 IMPACT ON THE KEY MANUFACTURERS
4.10.4 IMPACT ON THE PRICING
CHAPTER 5: ARTIFICIAL BLOOD MARKET BY TYPE
5.1 ARTIFICIAL BLOOD MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
5.2 ARTIFICIAL BLOOD MARKET OVERVIEW
5.3 HEMOGLOBIN-BASED OXYGEN CARRIERS
5.3.1 INTRODUCTION AND MARKET OVERVIEW
5.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.3.4 HEMOGLOBIN-BASED OXYGEN CARRIERS: GEOGRAPHIC SEGMENTATION
5.4 PERFLUROCARBON-BASED PRODUCTS
5.4.1 INTRODUCTION AND MARKET OVERVIEW
5.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.4.4 PERFLUROCARBON-BASED PRODUCTS: GEOGRAPHIC SEGMENTATION
5.5 RECOMBINANT FACTORS
5.5.1 INTRODUCTION AND MARKET OVERVIEW
5.5.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.5.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.5.4 RECOMBINANT FACTORS: GEOGRAPHIC SEGMENTATION
5.6 SYNTHETIC PLATELETS
5.6.1 INTRODUCTION AND MARKET OVERVIEW
5.6.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.6.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.6.4 SYNTHETIC PLATELETS: GEOGRAPHIC SEGMENTATION
5.7 PLASMA EXPANDERS
5.7.1 INTRODUCTION AND MARKET OVERVIEW
5.7.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.7.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.7.4 PLASMA EXPANDERS: GEOGRAPHIC SEGMENTATION
5.8 OTHERS
5.8.1 INTRODUCTION AND MARKET OVERVIEW
5.8.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.8.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.8.4 OTHERS: GEOGRAPHIC SEGMENTATION
CHAPTER 6: ARTIFICIAL BLOOD MARKET BY APPLICATION
6.1 ARTIFICIAL BLOOD MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
6.2 ARTIFICIAL BLOOD MARKET OVERVIEW
6.3 TRAUMATIC INJURIES
6.3.1 INTRODUCTION AND MARKET OVERVIEW
6.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.3.4 TRAUMATIC INJURIES: GEOGRAPHIC SEGMENTATION
6.4 BLOOD DISORDERS
6.4.1 INTRODUCTION AND MARKET OVERVIEW
6.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.4.4 BLOOD DISORDERS: GEOGRAPHIC SEGMENTATION
6.5 ANEMIA
6.5.1 INTRODUCTION AND MARKET OVERVIEW
6.5.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.5.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.5.4 ANEMIA: GEOGRAPHIC SEGMENTATION
6.6 SURGERIES
6.6.1 INTRODUCTION AND MARKET OVERVIEW
6.6.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.6.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.6.4 SURGERIES: GEOGRAPHIC SEGMENTATION
6.7 OTHERS
6.7.1 INTRODUCTION AND MARKET OVERVIEW
6.7.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.7.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.7.4 OTHERS: GEOGRAPHIC SEGMENTATION
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 COMPETITIVE LANDSCAPE
7.1.1 COMPETITIVE POSITIONING
7.1.2 ARTIFICIAL BLOOD SALES AND MARKET SHARE BY PLAYERS
7.1.3 INDUSTRY BCG MATRIX
7.1.4 HEAT MAP ANALYSIS
7.1.5 ARTIFICIAL BLOOD INDUSTRY CONCENTRATION RATIO (CR5 AND HHI)
7.1.6 TOP 5 ARTIFICIAL BLOOD PLAYERS MARKET SHARE
7.1.7 MERGERS AND ACQUISITIONS
7.1.8 BUSINESS STRATEGIES BY TOP PLAYERS
7.2 FLUORO2 THERAPEUTICS
7.2.1 COMPANY OVERVIEW
7.2.2 KEY EXECUTIVES
7.2.3 COMPANY SNAPSHOT
7.2.4 OPERATING BUSINESS SEGMENTS
7.2.5 PRODUCT PORTFOLIO
7.2.6 BUSINESS PERFORMANCE
7.2.7 KEY STRATEGIC MOVES AND RECENT DEVELOPMENTS
7.2.8 SWOT ANALYSIS
7.3 BAXTER INTERNATIONAL
7.4 NORTHFIELD LABORATORIES
7.5 PLASTICELL LIMITED
7.6 BIOPURE CORPORATION
7.7 DENTRITECH
7.8 ALPHA THERAPEUTIC CORP
7.9 SANGART
7.10 DEXTRO-SANG CORPORATION
CHAPTER 8: GLOBAL ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 MARKET OVERVIEW
8.2 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
8.2.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
8.2.2 PERFLUROCARBON-BASED PRODUCTS
8.2.3 RECOMBINANT FACTORS
8.2.4 SYNTHETIC PLATELETS
8.2.5 PLASMA EXPANDERS
8.2.6 OTHERS
8.3 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
8.3.1 TRAUMATIC INJURIES
8.3.2 BLOOD DISORDERS
8.3.3 ANEMIA
8.3.4 SURGERIES
8.3.5 OTHERS
CHAPTER 9: NORTH AMERICA ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.2 IMPACT OF COVID-19
9.3 KEY PLAYERS
9.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
9.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
9.4.2 PERFLUROCARBON-BASED PRODUCTS
9.4.3 RECOMBINANT FACTORS
9.4.4 SYNTHETIC PLATELETS
9.4.5 PLASMA EXPANDERS
9.4.6 OTHERS
9.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
9.5.1 TRAUMATIC INJURIES
9.5.2 BLOOD DISORDERS
9.5.3 ANEMIA
9.5.4 SURGERIES
9.5.5 OTHERS
9.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
9.6.1 U.S.
9.6.2 CANADA
9.6.3 MEXICO
CHAPTER 10: EUROPE ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.2 IMPACT OF COVID-19
10.3 KEY PLAYERS
10.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
10.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
10.4.2 PERFLUROCARBON-BASED PRODUCTS
10.4.3 RECOMBINANT FACTORS
10.4.4 SYNTHETIC PLATELETS
10.4.5 PLASMA EXPANDERS
10.4.6 OTHERS
10.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
10.5.1 TRAUMATIC INJURIES
10.5.2 BLOOD DISORDERS
10.5.3 ANEMIA
10.5.4 SURGERIES
10.5.5 OTHERS
10.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
10.6.1 GERMANY
10.6.2 U.K.
10.6.3 FRANCE
10.6.4 ITALY
10.6.5 RUSSIA
10.6.6 SPAIN
10.6.7 REST OF EUROPE
CHAPTER 11: ASIA-PACIFIC ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.2 IMPACT OF COVID-19
11.3 KEY PLAYERS
11.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
11.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
11.4.2 PERFLUROCARBON-BASED PRODUCTS
11.4.3 RECOMBINANT FACTORS
11.4.4 SYNTHETIC PLATELETS
11.4.5 PLASMA EXPANDERS
11.4.6 OTHERS
11.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
11.5.1 TRAUMATIC INJURIES
11.5.2 BLOOD DISORDERS
11.5.3 ANEMIA
11.5.4 SURGERIES
11.5.5 OTHERS
11.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
11.6.1 CHINA
11.6.2 INDIA
11.6.3 JAPAN
11.6.4 SINGAPORE
11.6.5 AUSTRALIA
11.6.6 NEW ZEALAND
11.6.7 REST OF APAC
CHAPTER 12: MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.2 IMPACT OF COVID-19
12.3 KEY PLAYERS
12.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
12.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
12.4.2 PERFLUROCARBON-BASED PRODUCTS
12.4.3 RECOMBINANT FACTORS
12.4.4 SYNTHETIC PLATELETS
12.4.5 PLASMA EXPANDERS
12.4.6 OTHERS
12.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
12.5.1 TRAUMATIC INJURIES
12.5.2 BLOOD DISORDERS
12.5.3 ANEMIA
12.5.4 SURGERIES
12.5.5 OTHERS
12.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
12.6.1 TURKEY
12.6.2 SAUDI ARABIA
12.6.3 IRAN
12.6.4 UAE
12.6.5 AFRICA
12.6.6 REST OF MEA
CHAPTER 13: SOUTH AMERICA ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.2 IMPACT OF COVID-19
13.3 KEY PLAYERS
13.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
13.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
13.4.2 PERFLUROCARBON-BASED PRODUCTS
13.4.3 RECOMBINANT FACTORS
13.4.4 SYNTHETIC PLATELETS
13.4.5 PLASMA EXPANDERS
13.4.6 OTHERS
13.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
13.5.1 TRAUMATIC INJURIES
13.5.2 BLOOD DISORDERS
13.5.3 ANEMIA
13.5.4 SURGERIES
13.5.5 OTHERS
13.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
13.6.1 BRAZIL
13.6.2 ARGENTINA
13.6.3 REST OF SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 RESEARCH OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.3 RESEARCH PROCESS
1.4 SCOPE AND COVERAGE
1.4.1 MARKET DEFINITION
1.4.2 KEY QUESTIONS ANSWERED
1.5 MARKET SEGMENTATION
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 BY TYPE
3.2 BY APPLICATION
CHAPTER 4: MARKET LANDSCAPE
4.1 PORTER'S FIVE FORCES ANALYSIS
4.1.1 BARGAINING POWER OF SUPPLIER
4.1.2 THREAT OF NEW ENTRANTS
4.1.3 THREAT OF SUBSTITUTES
4.1.4 COMPETITIVE RIVALRY
4.1.5 BARGAINING POWER AMONG BUYERS
4.2 INDUSTRY VALUE CHAIN ANALYSIS
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 OPPORTUNITIES
4.5.4 CHALLENGES
4.4 PESTLE ANALYSIS
4.5 TECHNOLOGICAL ROADMAP
4.6 REGULATORY LANDSCAPE
4.7 SWOT ANALYSIS
4.8 PRICE TREND ANALYSIS
4.9 PATENT ANALYSIS
4.10 ANALYSIS OF THE IMPACT OF COVID-19
4.10.1 IMPACT ON THE OVERALL MARKET
4.10.2 IMPACT ON THE SUPPLY CHAIN
4.10.3 IMPACT ON THE KEY MANUFACTURERS
4.10.4 IMPACT ON THE PRICING
CHAPTER 5: ARTIFICIAL BLOOD MARKET BY TYPE
5.1 ARTIFICIAL BLOOD MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
5.2 ARTIFICIAL BLOOD MARKET OVERVIEW
5.3 HEMOGLOBIN-BASED OXYGEN CARRIERS
5.3.1 INTRODUCTION AND MARKET OVERVIEW
5.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.3.4 HEMOGLOBIN-BASED OXYGEN CARRIERS: GEOGRAPHIC SEGMENTATION
5.4 PERFLUROCARBON-BASED PRODUCTS
5.4.1 INTRODUCTION AND MARKET OVERVIEW
5.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.4.4 PERFLUROCARBON-BASED PRODUCTS: GEOGRAPHIC SEGMENTATION
5.5 RECOMBINANT FACTORS
5.5.1 INTRODUCTION AND MARKET OVERVIEW
5.5.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.5.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.5.4 RECOMBINANT FACTORS: GEOGRAPHIC SEGMENTATION
5.6 SYNTHETIC PLATELETS
5.6.1 INTRODUCTION AND MARKET OVERVIEW
5.6.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.6.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.6.4 SYNTHETIC PLATELETS: GEOGRAPHIC SEGMENTATION
5.7 PLASMA EXPANDERS
5.7.1 INTRODUCTION AND MARKET OVERVIEW
5.7.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.7.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.7.4 PLASMA EXPANDERS: GEOGRAPHIC SEGMENTATION
5.8 OTHERS
5.8.1 INTRODUCTION AND MARKET OVERVIEW
5.8.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
5.8.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
5.8.4 OTHERS: GEOGRAPHIC SEGMENTATION
CHAPTER 6: ARTIFICIAL BLOOD MARKET BY APPLICATION
6.1 ARTIFICIAL BLOOD MARKET OVERVIEW SNAPSHOT AND GROWTH ENGINE
6.2 ARTIFICIAL BLOOD MARKET OVERVIEW
6.3 TRAUMATIC INJURIES
6.3.1 INTRODUCTION AND MARKET OVERVIEW
6.3.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.3.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.3.4 TRAUMATIC INJURIES: GEOGRAPHIC SEGMENTATION
6.4 BLOOD DISORDERS
6.4.1 INTRODUCTION AND MARKET OVERVIEW
6.4.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.4.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.4.4 BLOOD DISORDERS: GEOGRAPHIC SEGMENTATION
6.5 ANEMIA
6.5.1 INTRODUCTION AND MARKET OVERVIEW
6.5.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.5.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.5.4 ANEMIA: GEOGRAPHIC SEGMENTATION
6.6 SURGERIES
6.6.1 INTRODUCTION AND MARKET OVERVIEW
6.6.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.6.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.6.4 SURGERIES: GEOGRAPHIC SEGMENTATION
6.7 OTHERS
6.7.1 INTRODUCTION AND MARKET OVERVIEW
6.7.2 HISTORIC AND FORECASTED MARKET SIZE (2016-2028F)
6.7.3 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
6.7.4 OTHERS: GEOGRAPHIC SEGMENTATION
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 COMPETITIVE LANDSCAPE
7.1.1 COMPETITIVE POSITIONING
7.1.2 ARTIFICIAL BLOOD SALES AND MARKET SHARE BY PLAYERS
7.1.3 INDUSTRY BCG MATRIX
7.1.4 HEAT MAP ANALYSIS
7.1.5 ARTIFICIAL BLOOD INDUSTRY CONCENTRATION RATIO (CR5 AND HHI)
7.1.6 TOP 5 ARTIFICIAL BLOOD PLAYERS MARKET SHARE
7.1.7 MERGERS AND ACQUISITIONS
7.1.8 BUSINESS STRATEGIES BY TOP PLAYERS
7.2 FLUORO2 THERAPEUTICS
7.2.1 COMPANY OVERVIEW
7.2.2 KEY EXECUTIVES
7.2.3 COMPANY SNAPSHOT
7.2.4 OPERATING BUSINESS SEGMENTS
7.2.5 PRODUCT PORTFOLIO
7.2.6 BUSINESS PERFORMANCE
7.2.7 KEY STRATEGIC MOVES AND RECENT DEVELOPMENTS
7.2.8 SWOT ANALYSIS
7.3 BAXTER INTERNATIONAL
7.4 NORTHFIELD LABORATORIES
7.5 PLASTICELL LIMITED
7.6 BIOPURE CORPORATION
7.7 DENTRITECH
7.8 ALPHA THERAPEUTIC CORP
7.9 SANGART
7.10 DEXTRO-SANG CORPORATION
CHAPTER 8: GLOBAL ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 MARKET OVERVIEW
8.2 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
8.2.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
8.2.2 PERFLUROCARBON-BASED PRODUCTS
8.2.3 RECOMBINANT FACTORS
8.2.4 SYNTHETIC PLATELETS
8.2.5 PLASMA EXPANDERS
8.2.6 OTHERS
8.3 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
8.3.1 TRAUMATIC INJURIES
8.3.2 BLOOD DISORDERS
8.3.3 ANEMIA
8.3.4 SURGERIES
8.3.5 OTHERS
CHAPTER 9: NORTH AMERICA ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.2 IMPACT OF COVID-19
9.3 KEY PLAYERS
9.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
9.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
9.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
9.4.2 PERFLUROCARBON-BASED PRODUCTS
9.4.3 RECOMBINANT FACTORS
9.4.4 SYNTHETIC PLATELETS
9.4.5 PLASMA EXPANDERS
9.4.6 OTHERS
9.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
9.5.1 TRAUMATIC INJURIES
9.5.2 BLOOD DISORDERS
9.5.3 ANEMIA
9.5.4 SURGERIES
9.5.5 OTHERS
9.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
9.6.1 U.S.
9.6.2 CANADA
9.6.3 MEXICO
CHAPTER 10: EUROPE ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.2 IMPACT OF COVID-19
10.3 KEY PLAYERS
10.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
10.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
10.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
10.4.2 PERFLUROCARBON-BASED PRODUCTS
10.4.3 RECOMBINANT FACTORS
10.4.4 SYNTHETIC PLATELETS
10.4.5 PLASMA EXPANDERS
10.4.6 OTHERS
10.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
10.5.1 TRAUMATIC INJURIES
10.5.2 BLOOD DISORDERS
10.5.3 ANEMIA
10.5.4 SURGERIES
10.5.5 OTHERS
10.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
10.6.1 GERMANY
10.6.2 U.K.
10.6.3 FRANCE
10.6.4 ITALY
10.6.5 RUSSIA
10.6.6 SPAIN
10.6.7 REST OF EUROPE
CHAPTER 11: ASIA-PACIFIC ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.2 IMPACT OF COVID-19
11.3 KEY PLAYERS
11.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
11.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
11.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
11.4.2 PERFLUROCARBON-BASED PRODUCTS
11.4.3 RECOMBINANT FACTORS
11.4.4 SYNTHETIC PLATELETS
11.4.5 PLASMA EXPANDERS
11.4.6 OTHERS
11.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
11.5.1 TRAUMATIC INJURIES
11.5.2 BLOOD DISORDERS
11.5.3 ANEMIA
11.5.4 SURGERIES
11.5.5 OTHERS
11.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
11.6.1 CHINA
11.6.2 INDIA
11.6.3 JAPAN
11.6.4 SINGAPORE
11.6.5 AUSTRALIA
11.6.6 NEW ZEALAND
11.6.7 REST OF APAC
CHAPTER 12: MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.2 IMPACT OF COVID-19
12.3 KEY PLAYERS
12.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
12.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
12.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
12.4.2 PERFLUROCARBON-BASED PRODUCTS
12.4.3 RECOMBINANT FACTORS
12.4.4 SYNTHETIC PLATELETS
12.4.5 PLASMA EXPANDERS
12.4.6 OTHERS
12.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
12.5.1 TRAUMATIC INJURIES
12.5.2 BLOOD DISORDERS
12.5.3 ANEMIA
12.5.4 SURGERIES
12.5.5 OTHERS
12.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
12.6.1 TURKEY
12.6.2 SAUDI ARABIA
12.6.3 IRAN
12.6.4 UAE
12.6.5 AFRICA
12.6.6 REST OF MEA
CHAPTER 13: SOUTH AMERICA ARTIFICIAL BLOOD MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.2 IMPACT OF COVID-19
13.3 KEY PLAYERS
13.4 KEY MARKET TRENDS, GROWTH FACTORS AND OPPORTUNITIES
13.4 HISTORIC AND FORECASTED MARKET SIZE BY TYPE
13.4.1 HEMOGLOBIN-BASED OXYGEN CARRIERS
13.4.2 PERFLUROCARBON-BASED PRODUCTS
13.4.3 RECOMBINANT FACTORS
13.4.4 SYNTHETIC PLATELETS
13.4.5 PLASMA EXPANDERS
13.4.6 OTHERS
13.5 HISTORIC AND FORECASTED MARKET SIZE BY APPLICATION
13.5.1 TRAUMATIC INJURIES
13.5.2 BLOOD DISORDERS
13.5.3 ANEMIA
13.5.4 SURGERIES
13.5.5 OTHERS
13.6 HISTORIC AND FORECAST MARKET SIZE BY COUNTRY
13.6.1 BRAZIL
13.6.2 ARGENTINA
13.6.3 REST OF SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ARTIFICIAL BLOOD MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ARTIFICIAL BLOOD MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ARTIFICIAL BLOOD MARKET COMPETITIVE RIVALRY
TABLE 005. ARTIFICIAL BLOOD MARKET THREAT OF NEW ENTRANTS
TABLE 006. ARTIFICIAL BLOOD MARKET THREAT OF SUBSTITUTES
TABLE 007. ARTIFICIAL BLOOD MARKET BY TYPE
TABLE 008. HEMOGLOBIN-BASED OXYGEN CARRIERS MARKET OVERVIEW (2016-2028)
TABLE 009. PERFLUROCARBON-BASED PRODUCTS MARKET OVERVIEW (2016-2028)
TABLE 010. RECOMBINANT FACTORS MARKET OVERVIEW (2016-2028)
TABLE 011. SYNTHETIC PLATELETS MARKET OVERVIEW (2016-2028)
TABLE 012. PLASMA EXPANDERS MARKET OVERVIEW (2016-2028)
TABLE 013. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 014. ARTIFICIAL BLOOD MARKET BY APPLICATION
TABLE 015. TRAUMATIC INJURIES MARKET OVERVIEW (2016-2028)
TABLE 016. BLOOD DISORDERS MARKET OVERVIEW (2016-2028)
TABLE 017. ANEMIA MARKET OVERVIEW (2016-2028)
TABLE 018. SURGERIES MARKET OVERVIEW (2016-2028)
TABLE 019. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 020. NORTH AMERICA ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 021. NORTH AMERICA ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 022. N ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 023. EUROPE ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 024. EUROPE ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 025. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 026. ASIA PACIFIC ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 027. ASIA PACIFIC ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 028. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 030. MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 031. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 032. SOUTH AMERICA ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 033. SOUTH AMERICA ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 034. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 035. FLUORO2 THERAPEUTICS: SNAPSHOT
TABLE 036. FLUORO2 THERAPEUTICS: BUSINESS PERFORMANCE
TABLE 037. FLUORO2 THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 038. FLUORO2 THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. BAXTER INTERNATIONAL: SNAPSHOT
TABLE 039. BAXTER INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 040. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 041. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. NORTHFIELD LABORATORIES: SNAPSHOT
TABLE 042. NORTHFIELD LABORATORIES: BUSINESS PERFORMANCE
TABLE 043. NORTHFIELD LABORATORIES: PRODUCT PORTFOLIO
TABLE 044. NORTHFIELD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. PLASTICELL LIMITED: SNAPSHOT
TABLE 045. PLASTICELL LIMITED: BUSINESS PERFORMANCE
TABLE 046. PLASTICELL LIMITED: PRODUCT PORTFOLIO
TABLE 047. PLASTICELL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. BIOPURE CORPORATION: SNAPSHOT
TABLE 048. BIOPURE CORPORATION: BUSINESS PERFORMANCE
TABLE 049. BIOPURE CORPORATION: PRODUCT PORTFOLIO
TABLE 050. BIOPURE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. DENTRITECH: SNAPSHOT
TABLE 051. DENTRITECH: BUSINESS PERFORMANCE
TABLE 052. DENTRITECH: PRODUCT PORTFOLIO
TABLE 053. DENTRITECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. ALPHA THERAPEUTIC CORP: SNAPSHOT
TABLE 054. ALPHA THERAPEUTIC CORP: BUSINESS PERFORMANCE
TABLE 055. ALPHA THERAPEUTIC CORP: PRODUCT PORTFOLIO
TABLE 056. ALPHA THERAPEUTIC CORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. SANGART: SNAPSHOT
TABLE 057. SANGART: BUSINESS PERFORMANCE
TABLE 058. SANGART: PRODUCT PORTFOLIO
TABLE 059. SANGART: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. DEXTRO-SANG CORPORATION: SNAPSHOT
TABLE 060. DEXTRO-SANG CORPORATION: BUSINESS PERFORMANCE
TABLE 061. DEXTRO-SANG CORPORATION: PRODUCT PORTFOLIO
TABLE 062. DEXTRO-SANG CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ARTIFICIAL BLOOD MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ARTIFICIAL BLOOD MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ARTIFICIAL BLOOD MARKET COMPETITIVE RIVALRY
TABLE 005. ARTIFICIAL BLOOD MARKET THREAT OF NEW ENTRANTS
TABLE 006. ARTIFICIAL BLOOD MARKET THREAT OF SUBSTITUTES
TABLE 007. ARTIFICIAL BLOOD MARKET BY TYPE
TABLE 008. HEMOGLOBIN-BASED OXYGEN CARRIERS MARKET OVERVIEW (2016-2028)
TABLE 009. PERFLUROCARBON-BASED PRODUCTS MARKET OVERVIEW (2016-2028)
TABLE 010. RECOMBINANT FACTORS MARKET OVERVIEW (2016-2028)
TABLE 011. SYNTHETIC PLATELETS MARKET OVERVIEW (2016-2028)
TABLE 012. PLASMA EXPANDERS MARKET OVERVIEW (2016-2028)
TABLE 013. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 014. ARTIFICIAL BLOOD MARKET BY APPLICATION
TABLE 015. TRAUMATIC INJURIES MARKET OVERVIEW (2016-2028)
TABLE 016. BLOOD DISORDERS MARKET OVERVIEW (2016-2028)
TABLE 017. ANEMIA MARKET OVERVIEW (2016-2028)
TABLE 018. SURGERIES MARKET OVERVIEW (2016-2028)
TABLE 019. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 020. NORTH AMERICA ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 021. NORTH AMERICA ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 022. N ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 023. EUROPE ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 024. EUROPE ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 025. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 026. ASIA PACIFIC ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 027. ASIA PACIFIC ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 028. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 030. MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 031. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 032. SOUTH AMERICA ARTIFICIAL BLOOD MARKET, BY TYPE (2016-2028)
TABLE 033. SOUTH AMERICA ARTIFICIAL BLOOD MARKET, BY APPLICATION (2016-2028)
TABLE 034. ARTIFICIAL BLOOD MARKET, BY COUNTRY (2016-2028)
TABLE 035. FLUORO2 THERAPEUTICS: SNAPSHOT
TABLE 036. FLUORO2 THERAPEUTICS: BUSINESS PERFORMANCE
TABLE 037. FLUORO2 THERAPEUTICS: PRODUCT PORTFOLIO
TABLE 038. FLUORO2 THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 038. BAXTER INTERNATIONAL: SNAPSHOT
TABLE 039. BAXTER INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 040. BAXTER INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 041. BAXTER INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 041. NORTHFIELD LABORATORIES: SNAPSHOT
TABLE 042. NORTHFIELD LABORATORIES: BUSINESS PERFORMANCE
TABLE 043. NORTHFIELD LABORATORIES: PRODUCT PORTFOLIO
TABLE 044. NORTHFIELD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 044. PLASTICELL LIMITED: SNAPSHOT
TABLE 045. PLASTICELL LIMITED: BUSINESS PERFORMANCE
TABLE 046. PLASTICELL LIMITED: PRODUCT PORTFOLIO
TABLE 047. PLASTICELL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 047. BIOPURE CORPORATION: SNAPSHOT
TABLE 048. BIOPURE CORPORATION: BUSINESS PERFORMANCE
TABLE 049. BIOPURE CORPORATION: PRODUCT PORTFOLIO
TABLE 050. BIOPURE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 050. DENTRITECH: SNAPSHOT
TABLE 051. DENTRITECH: BUSINESS PERFORMANCE
TABLE 052. DENTRITECH: PRODUCT PORTFOLIO
TABLE 053. DENTRITECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 053. ALPHA THERAPEUTIC CORP: SNAPSHOT
TABLE 054. ALPHA THERAPEUTIC CORP: BUSINESS PERFORMANCE
TABLE 055. ALPHA THERAPEUTIC CORP: PRODUCT PORTFOLIO
TABLE 056. ALPHA THERAPEUTIC CORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 056. SANGART: SNAPSHOT
TABLE 057. SANGART: BUSINESS PERFORMANCE
TABLE 058. SANGART: PRODUCT PORTFOLIO
TABLE 059. SANGART: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 059. DEXTRO-SANG CORPORATION: SNAPSHOT
TABLE 060. DEXTRO-SANG CORPORATION: BUSINESS PERFORMANCE
TABLE 061. DEXTRO-SANG CORPORATION: PRODUCT PORTFOLIO
TABLE 062. DEXTRO-SANG CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ARTIFICIAL BLOOD MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ARTIFICIAL BLOOD MARKET OVERVIEW BY TYPE
FIGURE 012. HEMOGLOBIN-BASED OXYGEN CARRIERS MARKET OVERVIEW (2016-2028)
FIGURE 013. PERFLUROCARBON-BASED PRODUCTS MARKET OVERVIEW (2016-2028)
FIGURE 014. RECOMBINANT FACTORS MARKET OVERVIEW (2016-2028)
FIGURE 015. SYNTHETIC PLATELETS MARKET OVERVIEW (2016-2028)
FIGURE 016. PLASMA EXPANDERS MARKET OVERVIEW (2016-2028)
FIGURE 017. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 018. ARTIFICIAL BLOOD MARKET OVERVIEW BY APPLICATION
FIGURE 019. TRAUMATIC INJURIES MARKET OVERVIEW (2016-2028)
FIGURE 020. BLOOD DISORDERS MARKET OVERVIEW (2016-2028)
FIGURE 021. ANEMIA MARKET OVERVIEW (2016-2028)
FIGURE 022. SURGERIES MARKET OVERVIEW (2016-2028)
FIGURE 023. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 024. NORTH AMERICA ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. EUROPE ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. ASIA PACIFIC ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. SOUTH AMERICA ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ARTIFICIAL BLOOD MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ARTIFICIAL BLOOD MARKET OVERVIEW BY TYPE
FIGURE 012. HEMOGLOBIN-BASED OXYGEN CARRIERS MARKET OVERVIEW (2016-2028)
FIGURE 013. PERFLUROCARBON-BASED PRODUCTS MARKET OVERVIEW (2016-2028)
FIGURE 014. RECOMBINANT FACTORS MARKET OVERVIEW (2016-2028)
FIGURE 015. SYNTHETIC PLATELETS MARKET OVERVIEW (2016-2028)
FIGURE 016. PLASMA EXPANDERS MARKET OVERVIEW (2016-2028)
FIGURE 017. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 018. ARTIFICIAL BLOOD MARKET OVERVIEW BY APPLICATION
FIGURE 019. TRAUMATIC INJURIES MARKET OVERVIEW (2016-2028)
FIGURE 020. BLOOD DISORDERS MARKET OVERVIEW (2016-2028)
FIGURE 021. ANEMIA MARKET OVERVIEW (2016-2028)
FIGURE 022. SURGERIES MARKET OVERVIEW (2016-2028)
FIGURE 023. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 024. NORTH AMERICA ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. EUROPE ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. ASIA PACIFIC ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. MIDDLE EAST & AFRICA ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. SOUTH AMERICA ARTIFICIAL BLOOD MARKET OVERVIEW BY COUNTRY (2016-2028)